Sean Salmon sold $2.6M of MDT
EVP & President Cardiovascular at Medtronic plc. 30,695 shares at an average of $85.13, traded Feb 21, 2024, filed Feb 23, 2024.
Score components
- +15RoleOfficer
- +25Trade size$2.6M at market
- +10Share of holdings soldSold 39% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001613103-24-000008, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 21, 2024 | MOption exercise Ordinary Shares | +1,594 | $62.76 | $100k | 49,833 | Feb 23, 2024 |
| Feb 21, 2024 | MOption exercise Ordinary Shares | +13,066 | $62.76 | $820k | 62,949 | Feb 23, 2024 |
| Feb 21, 2024 | MOption exercise Ordinary Shares | +16,035 | $74.84 | $1.2M | 78,984 | Feb 23, 2024 |
| Feb 21, 2024 | SOpen-market sale Ordinary Shares | -1,594 | $85.06 | $136k | 77,390 | Feb 23, 2024 |
| Feb 21, 2024 | SOpen-market sale Ordinary Shares | -13,066 | $85.15 | $1.1M | 64,324 | Feb 23, 2024 |
| Feb 21, 2024 | SOpen-market sale Ordinary Shares | -16,035 | $85.12 | $1.4M | 48,289 | Feb 23, 2024 |
| Feb 21, 2024 | MOption exercise Stock Option (Right to Buy)derivative | -1,594 | $0.00 | $0 | 13,066 | Feb 23, 2024 |
| Feb 21, 2024 | MOption exercise Stock Option (Right to Buy)derivative | -13,066 | $0.00 | $0 | 0 | Feb 23, 2024 |
| Feb 21, 2024 | MOption exercise Stock Option (Right to Buy)derivative | -16,035 | $0.00 | $0 | 0 | Feb 23, 2024 |
Related signals
Other insiders at Medtronic plc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 26Weak | MDTsell Medtronic plc | Harry Skip Kiil EVP & President Cardiovascular | $139k 1,483 shares | -3% | |
| 8Weak | Medtronic plc | Matthew R. Walter SVP, Chief HR Officer | $258k 3,102 shares | -8% | |
| 35Weak | MDTsell Medtronic plc | Harry Skip Kiil EVP & President Cardiovascular | $337k 4,189 shares | -10% | |
| 45Moderate | MDTsell Medtronic plc | Harry Skip Kiil EVP & President Cardiovascular | $5.1M 52,524 shares | -62% | |
| 50Moderate | MDTsell Medtronic plc | Gregory L Smith EVP Global Ops & Supply Chain | $3.1M 30,000 shares | -39% | |
| 42Moderate | MDTsell Medtronic plc | Harry Skip Kiil EVP & President Cardiovascular | $788k 8,605 shares | -19% | |
| 40Moderate | MDTbuy Medtronic plc | William R Jellison director | $463k 5,000 shares | - | |
| 16Weak | Medtronic plc | Brett A. Wall EVP & Pres Neuroscience | $411k 4,997 shares | -15% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.